Skip to main content

Rubinstein-Taybi Syndrome 2

OMIM ID:

autosomal dominant

Rubinstein-Taybi Syndrome 2

Alternate Names

RSTS2

Defective Genes

EP300

Clinical Characteristics

Ocular Features

Highly-arched and bushy eyebrows are often seen.  The lashes are long and bushy and lid fissures tend to slope downward.

The ocular phenotype has not been fully described no doubt due to the rarity of cases.  Individuals with type 1 (RSTS1) have been described with congenital glaucoma, nystagmus, corneal abnormalities of shape (such as keratoglobus, sclerocornea, megalocornea), pigmentary retinopathy, and VEP evidence of rod and cone dysfunction have been described.

Systemic Features

The phenotype of RSTS2 is more variable than the somewhat similar RSTS1.  Less than 10% of individuals with Rubinstein-Taybi syndrome have type 2 while over 50% have type 1.  The facial dysmorphism nay be less severe in RSTS2.

Mild to moderate intellectual disability with psychosocial problems such as autism is nearly universal.  Microcephaly, a broad nasal bridge, a beaked nose, high-arched palate and some degree of micrognathia are characteristic.  The lower lip often appears ‘pouty’ and protrudes beyond the upper lip while the hard palate is highly arched.  Pregnancy may be complicated by pre-eclampsia and growth restriction.  Swallowing and feeding issues are common.  Syndactyly is often present and there is considerable variability in the size of the toes and thumbs.  Some patients with RSTS2 do not have evidence of the classic broad thumbs and toes characteristic of RSTS1.

Genetics

Inheritance

Heterozygous mutations in EP300 (22q13.2) have been found in this condition.  Virtually all cases occur de novo.  Rubinstein-Taybi Syndrome 1 (180849) is a phenotypically similar disorder resulting from a different mutation (CREBBP).

Pedigree

Autosomal dominant

Autosomal dominant disorders require only one mutation for the disease to be expressed.  Since an affected parent has two chromosomes, only one of which has the mutant gene, parents can expect that half (50%) of their children will receive that one and inherit the disease.  It is common for individuals that inherit the mutation, however, to not have evidence of the disease (nonpenetrance).

Image
Sample pedigree of autosomal dominant inheritance

Autosomal dominant inheritance leads to a vertical pattern of transmission

Treatment & Management

There is no treatment for this condition.

Publications

Displaying 1 - 3 of 3

Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum

PubMedID: 29506490

Rubinstein–Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum

PubMedID: 27465822

Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein–Taybi syndrome

PubMedID: 20014264